Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol-rich cannabis extract for Parkinson's disease symptoms and quality of life
TCTR20210303005Phase 0Completed
- Sponsor
- N/A
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, single-arm trial of cannabidiol in Parkinson's disease (PD), sponsored by N/A. Primary endpoints: Disease severity and Quality of life. Started Mar 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on TCTR20210303005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210303005.